Humana Posts 3Q EPS of $1.33
HUM has more than doubled off its 52-week low of $163.11.
Summary
Humana reported third-quarter EPS of $1.33. The headline gives the bottom-line figure only — no revenue, benefit ratio, or guidance update, so the comparison to the $7.61 adjusted EPS posted in Q2 and to consensus is not yet possible from this item. Context matters: the company reaffirmed FY2026 EPS guidance in a September 8-K and its 2027 Medicare Advantage Star Ratings came in strong in October, with 95% of members in 4-star-plus plans. The key question is whether the quarter's benefit ratio held near the 91.1% level seen in Q2, given the heavy Medicare membership growth. Full release details and any guidance revision will determine direction.
At the time of this announcement, HUM was trading at $408.50 on NYSE in the Life Sciences sector, with a market capitalization of approximately $49.4B. The 52-week trading range was $163.11 to $456.50. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.